Cardiovascular
Although mortality rates for cardiovascular diseases declined consistently over the decade 1998-2008, heart disease and stroke are still the number one killer in the US. This fact that illustrates why cardiovascular drugs and therapeutics is such a key sector of the pharmaceutical industry.
The reports, books, and subscriptions listed under Research and Markets’ Cardiovascular category explore in-depth vital areas such as the latest clinical trials for treatments for a variety of
afflictions such as hypertension, arrhythmia and stroke. Learn all the latest news about products and R&D of pharmaceutical companies, hospitals and universities, as well as the latest market trends in a wide selection of countries. Also featured is a selection of academic and clinical textbooks for those working at the coalface of cardiovascular pharmaceuticals.
Show Less
Read more
Orthostatic Hypotension - Pipeline Review, H1 2012
Orthostatic Hypotension – Pipeline Review, H1 2012
Summary
Global Markets Direct’s, 'Orthostatic Hypotension - Pipeline Review, H1 2012', provides an overview of the Orthostatic Hypotension therapeutic...
May
2012
FROM
EUR 382USD 500GBP 322AUD 532JPY 48,968SEK 3 311CHF 470CAD 520
Thromboembolism - Pipeline Review, H1 2012
Thromboembolism – Pipeline Review, H1 2012
Summary
Global Markets Direct’s, 'Thromboembolism - Pipeline Review, H1 2012', provides an overview of the Thromboembolism therapeutic pipeline. This report...
May
2012
FROM
EUR 382USD 500GBP 322AUD 532JPY 48,968SEK 3 311CHF 470CAD 520
Post-Myocardial Infarction - Pipeline Review, H1 2012
Post-Myocardial Infarction – Pipeline Review, H1 2012
Summary
Global Markets Direct’s, 'Post-Myocardial Infarction - Pipeline Review, H1 2012', provides an overview of the Post-Myocardial Infarction...
May
2012
FROM
EUR 382USD 500GBP 322AUD 532JPY 48,968SEK 3 311CHF 470CAD 520
Refractory Angina - Pipeline Review, H1 2012
Refractory Angina – Pipeline Review, H1 2012
Summary
Global Markets Direct’s, 'Refractory Angina - Pipeline Review, H1 2012', provides an overview of the Refractory Angina therapeutic pipeline. This...
May
2012
FROM
EUR 382USD 500GBP 322AUD 532JPY 48,968SEK 3 311CHF 470CAD 520
Vasculitis - Pipeline Review, H1 2012
Vasculitis – Pipeline Review, H1 2012
Summary
Global Markets Direct’s, 'Vasculitis - Pipeline Review, H1 2012', provides an overview of the Vasculitis therapeutic pipeline. This report provides information...
May
2012
FROM
EUR 382USD 500GBP 322AUD 532JPY 48,968SEK 3 311CHF 470CAD 520
Tachycardia (Tachyarrhythmias) - Pipeline Review, H1 2012
Tachycardia (Tachyarrhythmias) – Pipeline Review, H1 2012
Summary
Global Markets Direct’s, 'Tachycardia (Tachyarrhythmias) - Pipeline Review, H1 2012', provides an overview of the Tachycardia (Tachyarrhythmias)...
May
2012
FROM
EUR 382USD 500GBP 322AUD 532JPY 48,968SEK 3 311CHF 470CAD 520
Raynauds Disease - Pipeline Review, H1 2012
Raynauds Disease – Pipeline Review, H1 2012
Summary
Global Markets Direct’s, 'Raynauds Disease - Pipeline Review, H1 2012', provides an overview of the Raynauds Disease therapeutic pipeline. This...
May
2012
FROM
EUR 382USD 500GBP 322AUD 532JPY 48,968SEK 3 311CHF 470CAD 520
Myocardial Ischemia Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Myocardial Ischemia Global Clinical Trials Review, H1, 2012" provides data on the Myocardial...
May
2012
FROM
EUR 765USD 1,000GBP 645AUD 1,064JPY 97,935SEK 6 622CHF 941CAD 1,040
Chagas Cardiomyopathy Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Chagas Cardiomyopathy Global Clinical Trials Review, H1, 2012" provides data on the Chagas...
May
2012
FROM
EUR 765USD 1,000GBP 645AUD 1,064JPY 97,935SEK 6 622CHF 941CAD 1,040
Cardiac Arrest Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Cardiac Arrest Global Clinical Trials Review, H1, 2012" provides data on the Cardiac Arrest clinical...
May
2012
FROM
EUR 765USD 1,000GBP 645AUD 1,064JPY 97,935SEK 6 622CHF 941CAD 1,040
Hypotension Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Hypotension Global Clinical Trials Review, H1, 2012" provides data on the Hypotension clinical trial...
May
2012
FROM
EUR 765USD 1,000GBP 645AUD 1,064JPY 97,935SEK 6 622CHF 941CAD 1,040
Orthostatic Hypotension Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Orthostatic Hypotension Global Clinical Trials Review, H1, 2012" provides data on the Orthostatic...
May
2012
FROM
EUR 765USD 1,000GBP 645AUD 1,064JPY 97,935SEK 6 622CHF 941CAD 1,040
Hypoxemia Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Hypoxemia Global Clinical Trials Review, H1, 2012" provides data on the Hypoxemia clinical trial scenario....
May
2012
FROM
EUR 765USD 1,000GBP 645AUD 1,064JPY 97,935SEK 6 622CHF 941CAD 1,040
Chronic Stable Angina Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Chronic Stable Angina Global Clinical Trials Review, H1, 2012" provides data on the Chronic...
May
2012
FROM
EUR 765USD 1,000GBP 645AUD 1,064JPY 97,935SEK 6 622CHF 941CAD 1,040
Coronary Stenosis Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Coronary Stenosis Global Clinical Trials Review, H1, 2012" provides data on the Coronary Stenosis...
May
2012
FROM
EUR 765USD 1,000GBP 645AUD 1,064JPY 97,935SEK 6 622CHF 941CAD 1,040
GBI Research, the leading business intelligence provider, has released its latest research “Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent...
May
2012
FROM
EUR 2,677USD 3,500GBP 2,256AUD 3,724JPY 342,774SEK 23 176CHF 3'293CAD 3,639
GBI Research, the leading business intelligence provider, has released its latest research “Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent...
May
2012
FROM
EUR 2,677USD 3,500GBP 2,256AUD 3,724JPY 342,774SEK 23 176CHF 3'293CAD 3,639
Epidemiology: Stroke – Aging Global Population Leads to More Incident Cases of Stroke
Overview of stroke and atrial fibrillation definitions and a review of the epidemiology literature This report provides in-depth analysis of patient populations, a 10-year incident case forecast, and...
May
2012
FROM
EUR 2,907USD 3,800GBP 2,449AUD 4,044JPY 372,154SEK 25 162CHF 3'576CAD 3,951
Trends & Opportunities in Heart-Healthy Consumer Packaged Goods
Originally given at the SupplySide MarketPlace conference in New York City on May 9, 2012, this presentation reviews developments in the heart health market including trends related to functional ingredients,...
May
2012
FROM
EUR 1,143USD 1,495GBP 964AUD 1,591JPY 146,413SEK 9 899CHF 1'407CAD 1,555
Coronary Artery Disease (CAD) Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Coronary Artery Disease (CAD) Global Clinical Trials Review, H1, 2012" provides data...
May
2012
FROM
EUR 765USD 1,000GBP 645AUD 1,064JPY 97,935SEK 6 622CHF 941CAD 1,040
